|Bid||15.20 x N/A|
|Ask||15.70 x N/A|
|Day's Range||15.20 - 15.20|
|52 Week Range||14.90 - 19.90|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q4 2022 Paragon 28 Inc Earnings Call
Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -466.67% and 2.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ENGLEWOOD, Colo., March 02, 2023--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter and year ended December 31, 2022.